1. Ireland Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Medtronic Plc

Medtronic Plc

MDT
Medtronic PlcUS flagNew York Stock Exchange
95.45
USD
+1.22
- -
122.10BMarket Cap
Medtronic Plc
MDT
(New York Stock Exchange)

Recent

price

95.45

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
14.39
15.36
16.28
16.97
18.49
20.45
21.55
22.08
22.7
21.57
22.39
23.6
23.48
24.38
26.09
28.37
29.3
Revenue per Share
2.87
3.43
3.4
3.06
2.44
2.51
2.92
2.29
3.44
3.57
2.68
3.75
2.83
2.77
3.63
3.75
4.08
Basic EPS, GAAP
2.96
3.77
4.4
4.55
3.95
2.96
4.08
2.67
4.36
4.49
3.63
4.45
3.44
3.92
4.03
4.23
4.79
Free Cash Flow per Basic Share
0.9
0.97
1.04
1.11
1.22
1.52
1.72
1.84
2
2.16
2.32
2.52
2.72
2.76
2.79
2.84
2.85
Dividend per Share
14.92
16.5
18.38
19.46
37.44
37.21
36.66
37.45
37.36
37.83
38.23
39.49
38.69
38.29
37.46
38.64
39.24
Book Value per Share
3.48
4.37
5.58
6.57
-10.83
-11.68
-8.55
-7.79
-7.78
-6.09
-6.15
-2.66
-3.6
-3.05
-4.2
-2.55
-2.49
Tangible Book Value per Share
1,077
1,054
1,019
1,002
1,096
1,410
1,379
1,357
1,346
1,341
1,345
1,342
1,330
1,328
1,286
1,282
1,281
Basic Weighted Avg Shares
15,508
16,184
16,590
17,005
20,261
28,833
29,710
29,953
30,557
28,913
30,117
31,686
31,227
32,364
33,537
36,364
37,541
Sales/Revenue/Turnover
28.76
27.7
28.75
28.33
22.49
20.67
20.15
20.14
21.7
18.06
16.25
18.65
18.67
17.06
19.5
18.78
19.04
Operating Margin (%)
804
833
819
850
1,306
2,820
2,917
2,644
2,659
2,663
2,702
2,707
2,697
2,647
2,861
2,958
2,939
Depreciation Expense
3,096
3,617
3,467
3,065
2,675
3,538
4,028
3,104
4,631
4,789
3,606
5,039
3,758
3,676
4,662
4,801
5,231
Net Income, GAAP
16.62
17.61
18.44
17.27
23.26
18.4
12.56
45.46
10.53
- -
6.8
8.27
29.46
23.42
16.63
21.17
20.18
Effective Tax Rate (%)
19.96
22.35
20.9
18.02
13.2
12.27
13.56
10.36
15.16
16.56
11.97
15.9
12.03
11.36
13.9
13.2
13.93
Profit Margin (%)
4,424
10,409
13,902
15,651
21,671
16,435
10,609
12,896
13,495
11,665
14,039
10,665
12,624
11,146
10,935
13,129
12,591
Working Capital
7,934
7,192
9,691
10,259
33,673
30,020
25,881
23,705
24,477
22,021
26,378
20,372
24,344
23,932
25,642
26,173
25,617
LT Debt
15,968
17,113
18,671
19,443
53,230
52,063
50,330
50,822
50,212
50,872
51,602
52,722
51,665
50,420
48,256
50,072
50,850
Total Equity
14.88
13.88
13.67
13.14
5.75
5.6
6.24
4.07
7.74
- -
5.92
6.97
5.34
5.51
7.06
6.87
7.25
Return on Invested Capital (%)
13.95
14.68
13.31
11.15
5.28
5.42
5.98
4.66
7.76
- -
5.78
7.14
5.47
5.54
6.89
6.88
7.41
Return on Capital (%)
20.24
21.87
19.38
16.08
7.36
6.72
7.88
6.15
9.19
9.5
7.06
9.69
7.22
7.23
9.49
9.85
10.66
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jan'26
Apr'26
Jul'27
ST Debt
191
1,788
2,536
LT Borrowings
27,822
26,119
25,565
LT Finance Leases
58
54
52
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,283
1,280
1,280
Market Capitalization
132,135
103,656
109,303

Working Capital

FRC

•

in mil. unless spec.
Jan'26
Apr'26
Jul'27
Total Current Assets
24,071
24,787
24,390
Cash, Cash Equivalents & STI
8,383
9,220
8,819
Accounts Receivable, Net
6,359
6,643
6,357
Inventories
6,309
5,951
6,215
Total Current Liabilities
9,495
11,658
11,799
Payables & Accruals
6,723
7,192
7,357
ST Debt
191
1,788
2,536
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-0.36%
-0.55%
3.76%
Free Cash Flow
6.21%
3.38%
4.65%
Net Income, GAAP
6.07%
8.39%
2.98%
Sales/Revenue/Turnover
2.41%
3.89%
8.43%
Total Cash Common Dividend
5.53%
3.2%
1.39%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
7,915
8,403
8,292
8,927
33,537
2026
8,578
8,961
9,017
9,807
36,364
2027
9,756
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.81
0.99
1.01
0.82
3.63
2026
0.81
1.07
0.89
0.97
3.75
2027
1.15
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.69
0.7
0.7
0.7
2.79
2026
0.71
0.71
0.71
0.71
2.84
2027
0.72
- -
- -
- -
- -
Similar Companies
Allied Healthcare Products, Inc. (AHPIQ)
Endymed Ltd (ENDY.TA)
Ion Beam Applications S.A. (IBAB.BR)
CardieX Limited (CDX.AX)
Boston Scientific Corporation (BSX-PA)
NeuroMetrix, Inc. (NURO)
Business
Medtronic plc (NYSE: MDT) develops, manufactures, and markets a wide range of medical devices and therapies for the treatment of chronic diseases worldwide. The company offers products across four main segments: cardiovascular (including pacemakers, defibrillators, heart valves, and coronary stents under brands such as Evera, Protecta, and CoreValve); medical surgical (featuring surgical navigation systems, endoscopic tools, and stapling devices like Hugo RAS and Valiant NaviCore); neuroscience (encompassing spinal cord stimulators, deep brain stimulation systems, and intrathecal drug delivery pumps such as Incepta and SynchroMed II); and diabetes (primarily continuous glucose monitoring systems, insulin pumps, and related software through the MiniMed and Guardian brands). Medtronic provides services including patient management software, remote monitoring platforms, and clinical decision support tools to healthcare providers, hospitals, clinics, and patients globally. Founded in 1949 and headquartered in Dublin, Ireland, with principal executive offices in Minneapolis, Minnesota, USA, Medtronic operates in more than 150 countries, serving markets in North America, Europe, Asia-Pacific, Latin America, and the Middle East through direct sales forces, distributors, and subsidiaries. The company targets physicians, hospitals, ambulatory surgery centers, and home care settings, with a focus on minimally invasive therapies and digital health solutions. Key subsidiaries include Covidien (acquired in 2015 for surgical and patient monitoring products) and Intersect ENT (recently integrated for sinus implants). In the past 1-2 years, Medtronic has pursued strategic expansions including the FDA approval and U.S. launch of the Hugo robotic-assisted surgery (RAS) system in 2024 for soft tissue indications, building on its European CE Mark; a multi-year collaboration with NVIDIA announced in 2024 to advance AI-enabled therapies using Medtronic's Gigamon data platform; and the acquisition of Mazor Robotics in 2018 followed by ongoing enhancements to its spinal robotics portfolio with the Mazor X Stealth Edition. The company completed a $4.1 billion acquisition of Covidien assets integration and reported expansions in diabetes care via the Simplera Sync sensor FDA clearance in 2024. Medtronic also announced organizational realignments in 2025 to streamline its four operating units amid portfolio optimization efforts.

Company News

Company News APIChatGPT

  • defenseworld.net

    7,240 Medtronic PLC $MDT Shares Acquired by Krilogy Financial LLC

  • 247wallst.com

    Medtronic Pays More Today. Abbott Raises Its Dividend Faster.

  • prnewswire.com

    Medtronic Announces Final Results of MiniMed Group, Inc. Exchange Offer

  • defenseworld.net

    Medtronic PLC $MDT Shares Bought by Allied Investment Advisors LLC

  • zacks.com

    Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know

  • benzinga.com

    Top 10 Powder Keg Stocks Where Short Sellers Are Sitting on a Fuse

  • defenseworld.net

    13,074 Medtronic PLC $MDT Shares Acquired by NorthCrest Asset Manangement LLC

  • defenseworld.net

    Medtronic (NYSE:MDT) Shares Climb 4.1% – Should You Buy?

  • prnewswire.com

    Medtronic Announces Preliminary Results of MiniMed Group, Inc. Exchange Offer

  • fool.com

    Medtronic Is Just 1 Year From Dividend King Status. Should You Buy the Stock Before It Gets There?

  • 247wallst.com

    The Monopolistic Razor-and-Blade Engine I Can’t Stop Buying

  • benzinga.com

    Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

  • prnewswire.com

    Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.

  • fool.com

    The "Trumpflation" Trade Could Get Worse Before It Gets Better. History Says These 2 Stocks Are the Place to Hide.

  • 247wallst.com

    Better Dividend Play for Retirees: MDT or ABT? One Delivers Significantly More Yield

  • zacks.com

    Medtronic (MDT) Outperforms Broader Market: What You Need to Know

  • fool.com

    Why I Think These Are the 2 Smartest Stocks to Buy With $5,000 in October

  • defenseworld.net

    13,988 Medtronic PLC $MDT Shares Sold by Park National Corp OH

  • defenseworld.net

    Medtronic PLC $MDT Shares Sold by Argent Capital Management LLC

  • fool.com

    2 Beaten-Down Stocks Worth Buying and Holding for the Next Decade